These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 23189979)

  • 1. Genetics of inflammatory bowel diseases: a comparison between Western and Eastern perspectives.
    Cheon JH
    J Gastroenterol Hepatol; 2013 Feb; 28(2):220-6. PubMed ID: 23189979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and treatment of inflammatory bowel disease: a comparison of Eastern and Western perspectives.
    Park SJ; Kim WH; Cheon JH
    World J Gastroenterol; 2014 Sep; 20(33):11525-37. PubMed ID: 25206259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Studies of Inflammatory Bowel Disease-Focusing on Asian Patients.
    Park SC; Jeen YT
    Cells; 2019 May; 8(5):. PubMed ID: 31052430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Genes of Inflammatory Bowel Disease in Asia: What Are the Most Important Pathways Affected?
    Guo C; Wu K
    Dig Dis; 2016; 34(1-2):5-11. PubMed ID: 26982027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease.
    Holleran G; Lopetuso L; Petito V; Graziani C; Ianiro G; McNamara D; Gasbarrini A; Scaldaferri F
    Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28934123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation in inflammatory bowel disease and beyond.
    Low D; Mizoguchi A; Mizoguchi E
    World J Gastroenterol; 2013 Aug; 19(32):5238-49. PubMed ID: 23983426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics of inflammatory bowel disease in Asia: systematic review and meta-analysis.
    Ng SC; Tsoi KK; Kamm MA; Xia B; Wu J; Chan FK; Sung JJ
    Inflamm Bowel Dis; 2012 Jun; 18(6):1164-76. PubMed ID: 21887729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunochip Meta-Analysis of Inflammatory Bowel Disease Identifies Three Novel Loci and Four Novel Associations in Previously Reported Loci.
    Hong M; Ye BD; Yang SK; Jung S; Lee HS; Kim BM; Lee SB; Hong J; Baek J; Park SH; Han B; Li Y; Liu W; Haritunians T; Taylor KD; Rotter JI; Bang SY; Kim TH; McGovern DPB; Liu J; Song K
    J Crohns Colitis; 2018 May; 12(6):730-741. PubMed ID: 29584801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics of treatments for inflammatory bowel disease.
    Lucafò M; Franca R; Selvestrel D; Curci D; Pugnetti L; Decorti G; Stocco G
    Expert Opin Drug Metab Toxicol; 2018 Dec; 14(12):1209-1223. PubMed ID: 30465611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on pathogenesis and predictors of response of therapeutic strategies used in inflammatory bowel disease.
    Quetglas EG; Mujagic Z; Wigge S; Keszthelyi D; Wachten S; Masclee A; Reinisch W
    World J Gastroenterol; 2015 Nov; 21(44):12519-43. PubMed ID: 26640330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics of thiopurines for inflammatory bowel disease in East Asia: prospects for clinical application of NUDT15 genotyping.
    Kakuta Y; Kinouchi Y; Shimosegawa T
    J Gastroenterol; 2018 Feb; 53(2):172-180. PubMed ID: 29192347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance of advances in genetics and pharmacogenetics of IBD.
    Ahmad T; Tamboli CP; Jewell D; Colombel JF
    Gastroenterology; 2004 May; 126(6):1533-49. PubMed ID: 15168365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. East Meets West: The Increasing Incidence of Inflammatory Bowel Disease in Asia as a Paradigm for Environmental Effects on the Pathogenesis of Immune-Mediated Disease.
    Yang Y; Owyang C; Wu GD
    Gastroenterology; 2016 Dec; 151(6):e1-e5. PubMed ID: 27810482
    [No Abstract]   [Full Text] [Related]  

  • 14. Inflammatory bowel disease: pathogenesis.
    Zhang YZ; Li YY
    World J Gastroenterol; 2014 Jan; 20(1):91-9. PubMed ID: 24415861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory Bowel Disease Drugs: A Focus on Autophagy.
    Hooper KM; Barlow PG; Stevens C; Henderson P
    J Crohns Colitis; 2017 Jan; 11(1):118-127. PubMed ID: 27381462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunopathophysiology of inflammatory bowel disease: how genetics link barrier dysfunction and innate immunity to inflammation.
    Mehta M; Ahmed S; Dryden G
    Innate Immun; 2017 Aug; 23(6):497-505. PubMed ID: 28770665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic manifestations of inflammatory bowel disease differ between Hispanics and non-Hispanic whites: results of a large cohort study.
    Damas OM; Jahann DA; Reznik R; McCauley JL; Tamariz L; Deshpande AR; Abreu MT; Sussman DA
    Am J Gastroenterol; 2013 Feb; 108(2):231-9. PubMed ID: 23247580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Analysis of IL-10/IL-10R Genetic Factors Related to Risk of Colon Cancer and Inflammatory Bowel Disease in a Han Chinese Population.
    Cai J; Zhang Z
    Clin Lab; 2016; 62(6):1147-54. PubMed ID: 27468578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetics in inflammatory bowel disease.
    Jenke AC; Zilbauer M
    Curr Opin Gastroenterol; 2012 Nov; 28(6):577-84. PubMed ID: 23041674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTLA4 gene polymorphisms in Dutch and Chinese patients with inflammatory bowel disease.
    Xia B; Crusius JB; Wu J; Zwiers A; van Bodegraven AA; Peña AS
    Scand J Gastroenterol; 2002 Nov; 37(11):1296-300. PubMed ID: 12465728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.